BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9336663)

  • 1. Prospects for the development of fungal vaccines.
    Deepe GS
    Clin Microbiol Rev; 1997 Oct; 10(4):585-96. PubMed ID: 9336663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of vaccines and their use in the prevention of fungal infections.
    Dixon DM; Casadevall A; Klein B; Mendoza L; Travassos L; Deepe GS
    Med Mycol; 1998; 36 Suppl 1():57-67. PubMed ID: 9988493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for fungal infections.
    Tiwari U; Das S; Tandon M; Ramachandran VG; Saha R
    Natl Med J India; 2015; 28(1):14-9. PubMed ID: 26219316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
    Deepe GS
    Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection.
    Wüthrich M; Dobson HE; Ledesma Taira C; Okaa UJ; Dos Santos Dias L; Isidoro-Ayza M; Petrovsky N; Klein BS
    mBio; 2021 Aug; 12(4):e0201821. PubMed ID: 34399628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi.
    Wang Z; Shao J
    Arch Microbiol; 2024 Jun; 206(7):293. PubMed ID: 38850421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights on the development of fungal vaccines: from immunity to recent challenges.
    Medici NP; Del Poeta M
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):966-73. PubMed ID: 26602871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for development of vaccines against fungal diseases.
    Dan JM; Levitz SM
    Drug Resist Updat; 2006 Jun; 9(3):105-10. PubMed ID: 16820318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced humoral immunity and vaccination against major human fungal pathogens.
    Casadevall A; Feldmesser M; Pirofski LA
    Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvants and delivery systems for antifungal vaccines: current state and future developments.
    Portuondo DL; Ferreira LS; Urbaczek AC; Batista-Duharte A; Carlos IZ
    Med Mycol; 2015 Jan; 53(1):69-89. PubMed ID: 25362733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against fungal infections.
    Segal E
    Crit Rev Microbiol; 1987; 14(3):229-71. PubMed ID: 3556019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and prospects for a vaccine to prevent cryptococcosis.
    Casadevall A; Pirofski LA
    Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.
    Polonelli L; Casadevall A; Han Y; Bernardis F; Kirkland TN; Matthews RC; Adriani D; Boccanera M; Burnie JP; Cassone A; Conti S; Cutler JE; Frazzi R; Gregory C; Hodgetts S; Illidge C; Magliani W; Rigg G; Santoni G
    Med Mycol; 2000; 38 Suppl 1():281-92. PubMed ID: 11204156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligation of Dectin-2 with a novel microbial ligand promotes adjuvant activity for vaccination.
    Wang H; Lee TJ; Fites SJ; Merkhofer R; Zarnowski R; Brandhorst T; Galles K; Klein B; Wüthrich M
    PLoS Pathog; 2017 Aug; 13(8):e1006568. PubMed ID: 28793349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies in vaccination against fungal infections.
    Polonelli L; Poulain D; Cole GT; Conti S; Elad D; Gerloni M; Kirkland T; Matthews R; Segal E; Wyckoff E
    J Med Vet Mycol; 1994; 32 Suppl 1():105-12. PubMed ID: 7536837
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in combating fungal diseases: vaccines on the threshold.
    Cutler JE; Deepe GS; Klein BS
    Nat Rev Microbiol; 2007 Jan; 5(1):13-28. PubMed ID: 17160002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
    Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
    mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody immunity and invasive fungal infections.
    Casadevall A
    Infect Immun; 1995 Nov; 63(11):4211-8. PubMed ID: 7591049
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.
    Wüthrich M; Gern B; Hung CY; Ersland K; Rocco N; Pick-Jacobs J; Galles K; Filutowicz H; Warner T; Evans M; Cole G; Klein B
    J Clin Invest; 2011 Feb; 121(2):554-68. PubMed ID: 21206087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.